Ex vivo measures of LDL oxidative susceptibility predict carotid artery disease

Atherosclerosis

Volumn 179, Issue 1, 2005, Pages 147-153

  Hendrickson, Audrey ^a   McKinstry, Laura A ^a   Lewis, Julieann K ^a   Lum, Jeremy ^a   Louie, Andy ^a   Schellenberg, Gerard D ^c   Hatsukami, Thomas S ^c   Chait, Alan ^b   Jarvik, Gail P ^a,b,d  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Veterans Puget Sound Health Care System   (United States)

^d UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

Carotid artery disease; Oxidation; Smoking; Statin

Indexed keywords

ALPHA TOCOPHEROL; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; APOLIPOPROTEIN A1; FOLIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MULTIVITAMIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; CAROTID ARTERY DISEASE; CAROTID ARTERY OBSTRUCTION; CONTROLLED STUDY; CORRELATION ANALYSIS; EX VIVO STUDY; HUMAN; LIPID OXIDATION; LIPID PEROXIDATION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OXIDATION; PREDICTION; PRIORITY JOURNAL; SMOKING; STATISTICAL SIGNIFICANCE;

EID: 13844297544     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2004.09.015     Document Type: Article

References (57)

1. C. Murray, and A.D. Lopez Global mortality, disability, and the contribution of risk factors: global burden of disease study Lancet 349 1997 1436 1442
2. L.E. Chambless, A.R. Folsom, and L.X. Clegg Carotid wall thickness is predictive of incident clinical stroke: the Atherosclerosis Risk in Communities (ARIC) study Am J Epidemiol 151 2000 478 487
3. Y. Nagai, K. Kitagawa, and M. Sakaguchi Significance of earlier carotid atherosclerosis for stroke subtypes Stroke 32 2001 1780 1785
4. T. Mannami, M. Konishi, S. Baba, N. Nishi, and A. Terao Prevalence of asymptomatic carotid atherosclerotic lesions detected by high-resolution ultrasonography and its relation to cardiovascular risk factors in the general population of a Japanese city: the Suita study Stroke 28 1997 518 525
5. P.P. Mineva, I.C. Manchev, and D.I. Hadjiev Prevalence and outcome of asymptomatic carotid stenosis: a population-based ultrasonographic study Eur J Neurol 9 2002 383 388
6. D. Steinberg Low density lipoprotein oxidation and its pathobiological significance J Biol Chem 272 1997 20963 20966
7. T. Henriksen, E.M. Mahoney, and D. Steinberg Enhanced macrophage degradation of biologically modified low density lipoprotein Arteriosclerosis 3 1983 149 159
8. D. Steinberg, S. Parthasarathy, T.E. Carew, J.C. Khoo, and J.L. Witztum Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity N Engl J Med 320 1989 915 924
9. M. Haberland, D. Fong, and L. Cheng Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits Science 241 1988 215 218
10. H. Boyd, A.M. Gown, G. Wolfbauer, and A. Chait Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit Am J Pathol 135 1989 815 825
11. S. Yla-Herttuala, W. Palinski, and M.E. Rosenfeld Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man J Clin Invest 84 1989 1086 1095
12. S. Cushing, J.A. Berliner, and A.J. Valente Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells PNAS 87 1990 5134 5138
13. J. Berliner, M.C. Territo, and A. Sevanian Minimally modified low density lipoprotein stimulates monocyte endothelial interactions J Clin Invest 85 1990 1260 1266
14. T. Rajavashisth, A. Andalibi, and M.C. Territo Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins Nature 344 1990 254 257
15. T. Drake, K. Hannani, H.H. Fei, S. Lavi, and J.A. Berliner Minimally oxidized low-density lipoprotein induces tissue factor expression in cultured human endothelial cells Am J Pathol 138 1991 601 607
16. J. Weis, R.E. Pitas, B.D. Wilson, and G.M. Rodgers Oxidized low-density lipoprotein increases cultured human endothelial cell tissue factor activity and reduces protein C activation Faseb J 5 1991 2459 2465
17. F. Liao, J.A. Berliner, and M. Mehrabian Minimally modified low density lipoprotein is biologically active in vivo in mice J Clin Invest 87 1991 2253 2257
18. J. Mehta, J.L. Bryant Jr., and P. Mehta Reduction of nitric oxide synthase activity in human neutrophils by oxidized low-density lipoproteins. Reversal of the effect of oxidized low-density lipoproteins by high-density lipoproteins and l-arginine Biochem Pharmacol 50 1995 1181 1185
19. J. Berliner, and J.W. Heinecke The role of oxidized lipoproteins in atherosclerosis Free Radic Biol Med 20 1996 707 727
20. J. Salonen, S. Yla-Herttuala, and R. Yamamoto Autoantibody against oxidised LDL and progression of carotid atherosclerosis Lancet 339 1992 883 887
21. H. Ohmura, H. Mokuno, and M. Sawano Lipid compositional differences of small, dense low-density lipoprotein particle influence its oxidative susceptibility: possible implication of increased risk of coronary artery disease in subjects with phenotype B Metabolism 51 2002 1081 1087
22. J. Regnstrom, J. Nilsson, P. Tornvall, C. Landou, and A. Hamsten Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man Lancet 339 1992 1183 1186
23. M.L. Liu, K. Ylitalo, and J. Vakkilainen Susceptibility of LDL to oxidation in vitro and antioxidant capacity in familial combined hyperlipidemia: comparison of patients with different lipid phenotypes Ann Med 34 2002 48 54
24. K. Nishi, H. Itabe, and M. Uno Oxidized LDL in carotid plaques and plasma associates with plaque instability Arterioscler Thromb Vasc Biol 22 2002 1649 1654
25. E.B. Rimm, E.L. Giovannucci, and M.J. Stampfer Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals Am J Epidemiol 135 1992 1114 1126 discussion 1127-36
26. 2+ precipitation procedure for quantitation of high-density- lipoprotein cholesterol Clin Chem 28 1982 1379 1388
27. G.R. Warnick Enzymatic methods for quantification of lipoprotein lipids Methods Enzymol 129 1986 101 123
28. P.S. Bachorik, and J.J. Albers Precipitation methods for quantification of lipoproteins Methods Enzymol 129 1986 78 100
29. W.T. Friedewald, R.I. Levy, and D.S. Fredrickson Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin Chem 18 1972 499 502
30. A. Zambon, M.A. Austin, B.G. Brown, J.E. Hokanson, and J.D. Brunzell Effect of hepatic lipase on LDL in normal men and those with coronary artery disease Arterioscler Thromb 13 1993 147 153
31. S.M. Marcovina, J.J. Albers, L.O. Henderson, and W.H. Hannon International Federation of Clinical Chemistry Standardization Project for measurements of apolipoproteins A-I and B III. Comparability of apolipoprotein A-I values by use of international reference material Clin Chem 39 1993 773 781
32. H. Esterbauer, G. Striegl, H. Puhl, and M. Rotheneder Continuous monitoring of in vitro oxidation of human low density lipoprotein Free Radic Res Commun 6 1989 67 75
33. E. Tsai, I.B. Hirsch, J.D. Brunzell, and A. Chait Reduced plasma peroxyl radical trapping capacity and increased susceptibility of LDL to oxidation in poorly controlled IDDM Diabetes 43 1994 1010 1014
34. O. Ziouzenkova, A. Sevanian, P.M. Abuja, P. Ramos, and H. Esterbauer Copper can promote oxidation of LDL by markedly different mechanisms Free Radic Biol Med 24 1998 607 623
35. M.R. Naghii A suggested method for the prediction of the oxidation resistance of low density lipoprotein by determination of the lag time Nutr Health 16 2002 107 112
36. M. Meraviglia, E. Maggi, and G. Bellomo Autoantibodies against oxidatively modified lipoproteins and progression of carotid restenosis after carotid endarterectomy Stroke 33 2002 1139 1141
37. M. Crisby, G. Nordin-Fredriksson, and P.K. Shah Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization Circulation 103 2001 926 933
38. H.A. Kleinveld, P.N. Demacker, A.F. De Haan, and A.F. Stalenhoef Decreased in vitro oxidizability of low-density lipoprotein in hypercholesterolaemic patients treated with 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors Eur J Clin Invest 23 1993 289 295
39. P. Puddu, G.M. Puddu, and A. Muscari Current thinking in statin therapy Acta Cardiol 56 2001 225 231
40. H. Seeger, D. Wallwiener, and A.O. Mueck Additive antioxidative effect of hormone replacement therapy combined with a statin Clin Exp Obstet Gynecol 27 2000 179 181
41. F.Y. Jin, V.S. Kamanna, and M.L. Kashyap Niacin decreases removal of high-density lipoprotein apolipoprotein A-I but not cholesterol ester by Hep G2 cells. Implication for reverse cholesterol transport Arterioscler Thromb Vasc Biol 17 1997 2020 2028
42. J.M. King, J.R. Crouse, and J.G. Terry Evaluation of effects of unmodified niacin on fasting and postprandial plasma lipids in normolipidemic men with hypoalphalipoproteinemia Am J Med 97 1994 323 331
43. A. Zambon, J.E. Hokanson, B.G. Brown, and J.D. Brunzell Evidence for a new pathophysiological mechanism for coronary artery disease regression: hepatic lipase-mediated changes in LDL density Circulation 99 1999 1959 1964
44. A. Sasaki, K. Kondo, and Y. Sakamoto Smoking cessation increases the resistance of low-density lipoprotein to oxidation Atherosclerosis 130 1997 109 111
45. M.A. Pech-Amsellem, I. Myara, and M. Storogenko Enhanced modifications of low-density lipoproteins (LDL) by endothelial cells from smokers: a possible mechanism of smoking-related atherosclerosis Cardiovasc Res 31 1996 975 983
46. M. Reilly, N. Delanty, J.A. Lawson, and G.A. FitzGerald Modulation of oxidant stress in vivo in chronic cigarette smokers Circulation 94 1996 19 25
47. R. Siekmeier, P. Wulfroth, H. Wieland, W. Gross, and W. Marz Low-density lipoprotein susceptibility to in vitro oxidation in healthy smokers and nonsmokers Clin Chem 42 1996 524 530
48. D. Harats, M. Ben-Naim, and Y. Dabach Cigarette smoking renders LDL susceptible to peroxidative modification and enhanced metabolism by macrophages Atherosclerosis 79 1989 245 252
49. H. Prieme, K. Nyyssonen, and K. Gronbaek Randomized controlled smoking cessation study: transient increase in plasma high density lipoprotein but no change in lipoprotein oxidation resistance Scand J Clin Lab Invest 58 1998 11 18
50. F.W. van den Berkmortel, P.N. Demacker, H. Wollersheim, T. Thien, and A.F. Stalenhoef Smoking or its cessation does not alter the susceptibility to in vitro LDL oxidation Eur J Clin Invest 30 2000 972 979
51. I. Jialal, and C.J. Fuller Effect of vitamin E, vitamin C and beta-carotene on LDL oxidation and atherosclerosis Can J Cardiol 11 Suppl. G 1995 97G 103G
52. I. Jialal, and S.M. Grundy Effect of combined supplementation with alpha-tocopherol, ascorbate, and beta carotene on low-density lipoprotein oxidation Circulation 88 1993 2780 2786
53. C. Earnest, K.H. Cooper, A. Marks, and T.L. Mitchell Efficacy of a complex multivitamin supplement Nutrition 18 2002 738 742
54. N.G. Stephens, A. Parsons, and P.M. Schofield Randomised controlled trial of vitamin E in patients with coronary disease: cambridge heart antioxidant study (CHAOS) Lancet 347 1996 781 786
55. D. Vivekananthan, M.S. Penn, S.K. Sapp, A. Hsu, and E.J. Topol Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials Lancet 361 2003 2017 2023
56. D. Morel, M. de la Llera-Moya, and K.E. Friday Treatment of cholesterol-fed rabbits with dietary vitamins E and C inhibits lipoprotein oxidation but not development of atherosclerosis J Nutr 124 1994 2123 2130
57. A. Shaish, A. Daugherty, F. O'Sullivan, G. Schonfeld, and J.W. Heinecke Beta-carotene inhibits atherosclerosis in hypercholesterolemic rabbits J Clin Invest 96 1995 2075 2082